Fuji, Japan

Katsumi Mashita

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Other. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Katsumi Mashita. Retrieved from https://idiyas.com/inventor/katsumi-mashita

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:

goldMedal1 out of 834,601 
Other
 patents

Years Active: 2002

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Katsumi Mashita: Innovator in Pharmaceutical Composition

Introduction

Katsumi Mashita is a notable inventor based in Fuji, Japan. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative compositions that enhance stability and efficacy.

Latest Patents

Katsumi Mashita holds 1 patent for a stable pharmaceutical composition. This composition comprises (E)-3,5-dihydroxy-7-[4'-4"-fluorophenyl-2'-cyclopropyl-quinolin-3'-yl]-6-heptenoic acid, or its salt or ester. The aqueous solution or dispersion of this composition has a pH ranging from 6.8 to 8. It is designed to maintain good time-dependent stability, showing no change in outward appearance even after prolonged storage.

Career Highlights

Throughout his career, Katsumi Mashita has worked with various companies, contributing his expertise to the pharmaceutical industry. His work has been instrumental in developing formulations that meet high standards of stability and effectiveness.

Collaborations

Katsumi has collaborated with notable individuals in his field, including Hironori Sassa and Toyojiro Muramatsu. These collaborations have further enriched his contributions to pharmaceutical innovations.

Conclusion

Katsumi Mashita's work in developing stable pharmaceutical compositions showcases his dedication to advancing medical science. His innovative approach continues to influence the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…